The EMG / Nerve Conduction Velocity Blind Spot

Neurologists frequently order Electromyography (EMG) and Nerve Conduction Studies (NCS) to evaluate peripheral neuropathies. In Small Fiber Neuropathy, EMG/NCS tests are completely normal 100% of the time. Electrophysiological studies measure large-diameter, heavily myelinated motor and sensory fibers. Small unmyelinated C-fibers and thinly myelinated Aδ-fibers do not generate sufficient surface voltage to be detected on nerve conduction testing. Patients are frequently misdiagnosed with psychosomatic illness unless a formal 3-mm punch skin biopsy with Intraepidermal Nerve Fiber Density (IENFD) staining is performed PMID: 23880343.

Autonomic Vasomotor Denervation: How SFN Causes POTS

Small fiber neuropathy is not merely a chronic pain disorder; it is a profound cause of cardiovascular hemodynamic collapse in ME/CFS and Long COVID:

1. Somatosensory C-Fiber Loss

Destruction of sensory terminals produces classical neuropathic symptoms:

  • Burning feet, stinging dysesthesias, "electric buzz" sensations in extremities.
  • Allodynia (pain from light touch, bedsheets, or clothing).
  • Impaired thermal discrimination (inability to distinguish lukewarm from freezing water).

2. Autonomic Vasomotor Fiber Loss

Sympathetic postganglionic C-fibers innervate peripheral vascular smooth muscle:

  • Venous Pooling in POTS: When sympathetic nerves die back, lower-limb veins fail to vasoconstrict upon standing, causing blood to pool in the calves and splanchnic circulation.
  • Compensatory Tachycardia: The sinus node accelerates dramatically (ΔHR ≥ 30 bpm) to sustain cerebral perfusion, generating neuropathic POTS.
🔬

SFN Clinical Diagnostic Screener & IENFD Density Evaluator

Input your age, sex, and biopsy results (or symptom profile) to evaluate objective nerve density percentiles and generate an etiological workup checklist.

Clinical Sensory & Autonomic Symptom Inventory
5th Percentile Cutoff
6.8 fibers/mm
Diagnostic Status
PATHOLOGICAL SFN
Clinical Probability
Definite SFN (Biopsy Proven)
Recommended Action
Etiological Autoimmune Panel
Clinical Pathology Requisition Exhibit

      

Peer-Reviewed References & Consensus Guidelines

  1. Lauria G, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Eur J Neurol. 2010;17(7):903-912. PMID: 20642627
  2. Oaklander AL, et al. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia or chronic fatigue syndrome. Pain. 2013;154(11):2310-2316. PMID: 23880343
  3. Novak P, et al. Multisystem involvement in post-COVID-19 syndrome: Autonomic dysfunction, small fiber neuropathy, and exercise intolerance. J Am Heart Assoc. 2022;11(23):e027878. PMID: 36444855
  4. Systrom DM, et al. Unexplained exertional dyspnea and fatigue in Long COVID and ME/CFS: Small fiber neuropathy and invasive cardiopulmonary exercise testing. Chest. 2022;162(2):418-428.